US 10960085
Modulation of liver genes
granted A61KA61K2039/505A61K48/0058
Quick answer
US patent 10960085 (Modulation of liver genes) held by Sangamo Therapeutics, Inc. expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K48/0058, A61P, A61P11/00